205 results on '"Witzel, I."'
Search Results
2. Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers
3. Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry
4. Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force
5. 208P Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases: A subanalysis of the German brain metastases in breast cancer registry (BMBC)
6. Breast cancer during pregnancy: from preclinical models to clinical studies
7. Long-term survival of HER2-positive breast cancer patients with brain metastases: subanalysis of the BMBC Registry
8. Meningeosis Carcinomatosa (MC) als Erstmanifestation einer Metastasierung bei triple – negativem Mammakarzinom unter (neo-)/adjuvanter Therapie — zwei Fallberichte
9. 269P Long-term survival of HER2-positive breast cancer patients with brain metastases: Subanalysis of the BMBC registry
10. 151P Tumor biology and immunology in patients (pts) with breast cancer occurring during pregnancy (BCP) compared to non-pregnant breast cancer pts
11. Long-term survival of HER2-positive breast cancer patients with brain metastases: Subanalysis of the BMBC registry
12. Long-term survival of breast cancer patients with brain metastases: Subanalysis of the BMBC registry
13. 170P Long-term survival of breast cancer patients with brain metastases: Subanalysis of the BMBC registry
14. 311P A global survey of the management of carcinomatous meningitis (CM) in breast cancer patients
15. Characteristics of patients with brain metastases from HER2-positive breast cancer
16. 95MO Characteristics of patients with brain metastases from HER2-positive breast cancer
17. Clinical-pathological Characterization of 1078 Advice Seekers with pathogenic CHEK2 Mutation from the German Consortium of Familial Breast and Ovarian Cancer (DK-FBREK)
18. The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use
19. 44O Pembrolizumab (pembro) vs chemotherapy (chemo) for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-119 Asia-Pacific subpopulation
20. Charakteristika und Überlebensanalyse der Patienten mit asymptomatischen Hirnmetastasen eines Mammakarzinoms
21. Kommunikationsprozesse zwischen BRCA-Mutationsträger/innen und deren Familienangehörigen
22. Klinisch-pathologische Charakterisierung von 1078 Ratsuchenden mit pathogener CHEK2 Mutation aus dem Deutschen Konsortium Familiärer Brust- und Eierstockkrebs (DK-FBREK)
23. Diagnostik und Behandlung von Brustimplantat-assoziierten anaplastischen Lymphomen (Bia-ALCL) – ein Case Report
24. 149P Predicting prognosis of breast cancer patients with brain metastases in the BMBC registry: Comparison of three different prognostic scores
25. Trastuzumab in pregnancy associated with poor fetal outcome
26. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.
27. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
28. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
29. KEYNOTE-119: Phase III study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple negative breast cancer (mTNBC)
30. PRECYCLE: Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy
31. New structures of the German Consortium for Hereditary Breast and Ovarian Cancer
32. Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer
33. Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients
34. Auftreten genitaler Verletzungen bei Frauen nach Sexualdelikten – unizentrische Analyse zur Bedeutung der gynäkologischen Untersuchungen
35. The clinical relevance of circulating tumor cells in correlation to other serum biomarkers (VEGF, HER2, EGFR, TIMP1, CAIX, RASp21) in patients with metastatic breast cancer
36. Validierung des Breast-GPA Scores bei Patientinnen mit Hirnmetastasen eines Mammakarzinoms im BMBC-Register (GBG-79)
37. Abstract P2-02-15: Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer
38. Expression Levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in Primary Breast Carcinoma and Distant Breast Cancer Metastases
39. Abstract P5-08-21: The effect of family history on screening procedures and prognosis in breast cancer patients – Results of a large population-based case–control study on breast cancer
40. Evaluation von Option Grids zur Unterstützung der Partizipativen Entscheidungsfindung in der Brustkrebsbehandlung – ein Studienprotokoll
41. Evaluation von Option Grids zur Unterstützung der Partizipativen Entscheidungsfindung in der Brustkrebsbehandlung
42. LBA21 - KEYNOTE-119: Phase III study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple negative breast cancer (mTNBC)
43. 389TiP - PRECYCLE: Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy
44. Die Rolle der Mannosidase MAN1A1 für die Progression und Metastasierung von Mammakarzinomen
45. Brain Metastases in Breast Cancer Network Germany (BMBC, GBG 79): aktueller Stand und Analyse der Patientendaten des Hirnmetastasenregisters
46. Abstract P6-17-08: Brain metastases in breast cancer network Germany (BMBC, GBG 79): First analysis of 548 patients from the multicenter registry
47. Abstract P5-07-03: Prosigna® results impact on adjuvant decision making in early breast cancer (EBC): Final analysis of the prospective WSG study
48. Abstract P6-17-06: Relevance of the hyaluronidase-1 (HYAL1) in brain metastasis formation of breast cancer patients
49. Identifying common genetic risk factors of diabetic neuropathies
50. Partial PTEN deletion is linked to poor prognosis in breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.